Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
British Columbia Discovery Fund (VCC) Inc. is a venture capital corporation based in Vancouver, Canada, that focuses on investing in early-stage technology and life science companies. Managed by Discovery Capital Management, the fund was designed to provide equity capital to high-growth businesses within British Columbia while offering tax incentives to provincial investors. Its portfolio has historically included significant holdings in the biotechnology and healthcare sectors, featuring companies such as Xenon Pharmaceuticals and Verisante Technology. The fund is currently in an orderly liquidation phase, focused on divesting its remaining assets and returning capital to its shareholders. As a result, it is no longer making new investments but continues to manage its existing portfolio toward final exits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on British Columbia Discovery Fund.